Literature DB >> 31611275

A Rare Opportunist, Morganella morganii, Decreases Severity of Polymicrobial Catheter-Associated Urinary Tract Infection.

Brian S Learman1, Aimee L Brauer1, Kathryn A Eaton2, Chelsie E Armbruster3.   

Abstract

Catheter-associated urinary tract infections (CAUTIs) are common hospital-acquired infections and frequently polymicrobial, which complicates effective treatment. However, few studies experimentally address the consequences of polymicrobial interactions within the urinary tract, and the clinical significance of polymicrobial bacteriuria is not fully understood. Proteus mirabilis is one of the most common causes of monomicrobial and polymicrobial CAUTI and frequently cocolonizes with Enterococcus faecalis, Escherichia coli, Providencia stuartii, and Morganella morganii P. mirabilis infections are particularly challenging due to its potent urease enzyme, which facilitates formation of struvite crystals, catheter encrustation, blockage, and formation of urinary stones. We previously determined that interactions between P. mirabilis and other uropathogens can enhance P. mirabilis urease activity, resulting in greater disease severity during experimental polymicrobial infection. Our present work reveals that M. morganii acts on P. mirabilis in a contact-independent manner to decrease urease activity. Furthermore, M. morganii actively prevents urease enhancement by E. faecalis, P. stuartii, and E. coli Importantly, these interactions translate to modulation of disease severity during experimental CAUTI, predominantly through a urease-dependent mechanism. Thus, products secreted by multiple bacterial species in the milieu of the catheterized urinary tract can directly impact prognosis.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  CAUTI; Enterococcus faecaliszzm321990; Escherichia colizzm321990; Morganella morganiizzm321990; Proteus mirabiliszzm321990; UTI; bacteremia; bacterial infections; catheter; medical devices; polymicrobial; pyelonephritis; urease; urinary tract infection; urolithiasis

Mesh:

Substances:

Year:  2019        PMID: 31611275      PMCID: PMC6921659          DOI: 10.1128/IAI.00691-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  76 in total

Review 1.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

Review 2.  New strategies to prevent catheter-associated urinary tract infections.

Authors:  Danish M Siddiq; Rabih O Darouiche
Journal:  Nat Rev Urol       Date:  2012-04-17       Impact factor: 14.432

3.  Urease-positive bacteriuria and obstruction of long-term urinary catheters.

Authors:  H L Mobley; J W Warren
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

4.  Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.

Authors:  Thomas M Hooton; Suzanne F Bradley; Diana D Cardenas; Richard Colgan; Suzanne E Geerlings; James C Rice; Sanjay Saint; Anthony J Schaeffer; Paul A Tambayh; Peter Tenke; Lindsay E Nicolle
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

5.  Bacteremia in a multilevel geriatric hospital.

Authors:  Emily Lubart; Refael Segal; Ella Haimov; Michael Dan; Yehuda Baumoehl; Arthur Leibovitz
Journal:  J Am Med Dir Assoc       Date:  2010-09-25       Impact factor: 4.669

6.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.

Authors:  H L Mobley; D M Green; A L Trifillis; D E Johnson; G R Chippendale; C V Lockatell; B D Jones; J W Warren
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

7.  Molecular epidemiology of catheter-associated bacteriuria in nursing home patients.

Authors:  G Rahav; E Pinco; F Silbaq; H Bercovier
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.

Authors:  Praveen Alamuri; Kathryn A Eaton; Stephanie D Himpsl; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2008-11-24       Impact factor: 3.441

9.  The attributable cost of catheter-associated urinary tract infections in the United States: A systematic review.

Authors:  Christopher S Hollenbeak; Amber L Schilling
Journal:  Am J Infect Control       Date:  2018-02-22       Impact factor: 2.918

10.  Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.

Authors:  Jann-Tay Wang; Pei-Chen Chen; Shan-Chwen Chang; Yih-Ru Shiau; Hui-Ying Wang; Jui-Fen Lai; I-Wen Huang; Mei-Chen Tan; Tsai-Ling Yang Lauderdale
Journal:  BMC Infect Dis       Date:  2014-09-05       Impact factor: 3.090

View more
  6 in total

1.  Enhanced Antibiotic Tolerance of an In Vitro Multispecies Uropathogen Biofilm Model, Useful for Studies of Catheter-Associated Urinary Tract Infections.

Authors:  Jiapeng Hou; Lutian Wang; Martin Alm; Peter Thomsen; Tor Monsen; Madeleine Ramstedt; Mette Burmølle
Journal:  Microorganisms       Date:  2022-06-13

Review 2.  Molecular Methodologies for Improved Polymicrobial Sepsis Diagnosis.

Authors:  Mariam Doualeh; Matthew Payne; Edward Litton; Edward Raby; Andrew Currie
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  Enterococcus faecalis Polymicrobial Interactions Facilitate Biofilm Formation, Antibiotic Recalcitrance, and Persistent Colonization of the Catheterized Urinary Tract.

Authors:  Jordan R Gaston; Marissa J Andersen; Alexandra O Johnson; Kirsten L Bair; Christopher M Sullivan; L Beryl Guterman; Ashely N White; Aimee L Brauer; Brian S Learman; Ana L Flores-Mireles; Chelsie E Armbruster
Journal:  Pathogens       Date:  2020-10-13

4.  Complete Genome Sequence of Morganella morganii CTX51T, Isolated from a Human Cecal Adenocarcinoma.

Authors:  Marija Stepanovica; Martha A Zepeda-Rivera; Adam S McGlinchey; Alexander A Baryiames; Dakota S Jones; Kaitlyn D LaCourse; Susan Bullman; Christopher D Johnston
Journal:  Microbiol Resour Announc       Date:  2022-03-07

5.  Morganella morganii: An unusual analysis of 11 cases of pediatric urinary tract infections.

Authors:  Huixuan Shi; Xianrui Chen; Yonghua Yao; Jinping Xu
Journal:  J Clin Lab Anal       Date:  2022-03-29       Impact factor: 3.124

6.  Prospective assessment of catheter-associated bacteriuria clinical presentation, epidemiology, and colonization dynamics in nursing home residents.

Authors:  Chelsie E Armbruster; Aimee L Brauer; Monica S Humby; Jiahui Shao; Saptarshi Chakraborty
Journal:  JCI Insight       Date:  2021-10-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.